Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)
China · Delayed Price · Currency is CNY 50.98
0.00 (0.00%)
Sep 2, 2026, 4:00 PM EDT
SHE:301617 Revenue
Shandong Boyuan Pharmaceutical & Chemical had revenue of 391.13M CNY in the quarter ending March 31, 2026, with 22.14% growth. This brings the company's revenue in the last twelve months to 1.54B, up 14.57% year-over-year. In the year 2025, Shandong Boyuan Pharmaceutical & Chemical had annual revenue of 1.46B with 10.30% growth.
Revenue (ttm)
1.54B
Revenue Growth
+14.57%
P/S Ratio
5.77
Revenue / Employee
2.05M
Employees
748
Market Cap
8.86B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.46B | 136.80M | 10.30% |
| Dec 31, 2024 | 1.33B | 302.73M | 29.53% |
| Dec 31, 2023 | 1.03B | 226.68M | 28.39% |
| Dec 31, 2022 | 798.47M | 274.10M | 52.27% |
| Dec 31, 2021 | 524.37M | 144.93M | 38.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Hunan Zhongke Electric | 10.06B |
| C&S Paper Co.,Ltd | 8.86B |
| Yizumi Holdings | 6.40B |
| Jiangsu Zhongli Group Co.,Ltd | 2.98B |
| Shenzhen Fenda Technology | 2.80B |
| Edifier Technology | 2.71B |
| Shenzhen Leaguer | 2.45B |
| Huabao Technology | 1.46B |